Clinical Trial

A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This study is an open-label, fixed-sequence, self-controlled Phase I clinical trial conducted among obese or overweight subjects, with a planned enrollment of 40 adult subjects.
Protocol Amendment History 3 changes
critical Trial completed 2026-04-16
notable Primary completion pushed: 2026-02 -> 2026-03-08 2026-04-16
minor Completion pushed: 2026-02 -> 2026-03-08 2026-04-16
Trial Details
NCT Number NCT07269756
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Obesity, Overweight
Enrollment 40 participants
Start Date 2025-12-07
Primary Completion 2026-03-08 (estimated)
Study Completion 2026-03-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-29